文献速递其他结缔组织病

儿童期起病干燥综合征的药物治疗策略:系统综述

Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该系统综述纳入截至2020年12月的文献,共43项研究(34例病例报告、8个小病例系列和1项试点研究),总结儿童期起病干燥综合征(SS)的药物治疗策略。研究发现用药多基于专家意见,包括羟氯喹(HCQ)、糖皮质激素、利妥昔单抗及其他传统改善病情抗风湿药(DMARDs),但目前缺乏高质量研究以形成临床推荐。

要点

  • 儿童期起病SS治疗药物包括HCQ、糖皮质激素、利妥昔单抗及传统DMARDs。
  • 用药选择主要基于专家临床经验,缺乏循证指南。
  • 现有研究证据等级很低,无法形成临床推荐。

核心结论

  • 儿童期起病SS的治疗多种多样,均基于专家意见,目前没有高质量研究支持临床推荐。

研究设计与样本

  • 系统综述,检索PubMed和MEDLINE/Scopus数据库截至2020年12月的文献,排除动物研究,最终纳入43项研究(34例病例报告、8个小病例系列和1项试点研究)。

主要发现

  • 纳入研究中88%(120/137)的病例为女孩,证据置信水平非常低。
  • HCQ用于治疗腮腺肿胀,并与MTX和NSAIDs联用于关节炎和关节痛患者。
  • 糖皮质激素(如长期口服泼尼松和静脉甲泼尼龙)常用于严重疾病表现的儿童。
  • 利妥昔单抗主要用于黏膜相关淋巴组织淋巴瘤及肾脏和神经系统并发症。
  • 其他传统DMARDs用于选定的有腺外表现的患者。

临床怎么用

  • 临床实践中,儿童期起病SS的治疗应根据专家意见个体化选择药物,并关注证据局限性。

局限性

  • 疾病罕见且研究匮乏,纳入研究多为病例报告和小病例系列,证据置信水平非常低,缺乏高质量研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: SS with childhood onset is a rare autoimmune disease characterized by heterogeneous presentation. The lack of validated classification criteria makes it challenging to diagnose. Evidence-based guidelines for treatment of juvenile SS are not available due to the rarity of disease and the paucity of research in this patient population. This systematic review aims to summarize and appraise the current literature focused on pharmacological strategies for management of SS with childhood onset. METHODS: PubMed and MEDLINE/Scopus databases up to December 2020 were screened for suitable reports highlighting pharmacological treatment of SS with childhood onset using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009 reporting checklist. Animal studies were excluded. RESULTS: A total of 43 studies (34 case reports, 8 mini case series and 1 pilot study) were eligible for analysis. The studies retrieved included girls in 88% (120/137) of cases and had very low confidence levels. HCQ was prescribed for parotid swelling, as well as in association with MTX and NSAIDs in patients with arthritis and arthralgia. Corticosteroids such as long courses of oral prednisone and i.v. methylprednisolone were commonly prescribed for children with severe disease presentations. Rituximab was mainly indicated for mucosa-associated lymphoid tissue lymphoma and renal and nervous system complications. Other conventional DMARDs were prescribed in selected cases with extraglandular manifestations. CONCLUSION: Various therapies are used for the management of juvenile SS and are prescribed based on expert clinician's opinion. There are currently no good-quality studies that allow clinical recommendations for treatment of SS with childhood onset.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Doolan G, Faizal NM, Foley C, et al. Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature. Rheumatology (Oxford). 2022. PMID: 34289032. doi:10.1093/rheumatology/keab579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。